Kezar Life Sciences, Inc. (KZR) Reports Q2 Loss of $0.30/sh

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported Q2 EPS of ($0.30), versus ($0.34) reported last year.

For earnings history and earnings-related data on Kezar Life Sciences, Inc. (KZR) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Outdoor Holding (POWW) PT Raised to $2.75 at Roth/MKM, reiterates Top Pick
• Stephens Reiterates Equal Weight Rating on Wendy's (WEN) on CFO change